Largest pharmaceuticals by total debt
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Definium Therapeutics has the lowest figure of the 35 pharmaceuticals ranked by total debt, at AED 149M, followed by Rhythm Pharmaceuticals (AED 397.3M) and Axsome Therapeutics (AED 689.5M). Figures as of 18 Nov 2026, 16:31 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 35
- Lowest
- Definium TherapeuticsAED 149M
- Median
- AED 19.4B
- Combined market value
- AED 18.7T
- Countries
- 10
- Not ranked
- 26no total debt on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total debt ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Definium TherapeuticsDFTX · Health Care | AED 149M | AED 14.4B | AED 105.14 | 2.55% down | 169% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | AED 397.3M | AED 29.8B | AED 430.53 | 0.53% up | 13% up | ||
| 3 | Axsome TherapeuticsAXSM · Health Care | AED 689.5M | AED 25.8B | AED 489.64 | 1.93% down | 7% down | ||
| 4 | Dr. Reddy's LaboratoriesRDY · Health Care | AED 711.5M | AED 45.9B | AED 55.03 | 1.32% up | 5% up | ||
| 5 | Cogent BiosciencesCOGT · Health Care | AED 818.6M | AED 18B | AED 103.71 | 1.40% up | 20% down | ||
| 6 | TG TherapeuticsTGTX · Health Care | AED 902.1M | AED 36.2B | AED 239.37 | 3.94% up | 107% up | ||
| 7 | CytokineticsCYTK · Health Care | AED 1.1B | AED 26.2B | AED 187.96 | 0.91% down | 20% down | ||
| 8 | Legend BiotechLEGN · Health Care | AED 1.2B | AED 11.6B | AED 59.73 | 0.96% up | 42% down | ||
| 9 | Madrigal PharmaceuticalsMDGL · Health Care | AED 1.2B | AED 34.8B | AED 1,499.85 | 3.22% down | 24% down | ||
| 10 | InsmedINSM · Health Care | AED 2B | AED 96.8B | AED 441.07 | 1.44% down | 40% down | ||
| 11 | Ascendis PharmaASND · Health Care | AED 2.9B | AED 65B | AED 991.02 | 0.49% down | 28% up | ||
| 12 | BeOne MedicinesONC · Health Care | AED 3.8B | AED 169.5B | AED 1,484.06 | 2.22% down | 17% up | ||
| 13 | Ionis PharmaceuticalsIONS · Health Care | AED 6.7B | AED 16.7B | AED 100.15 | 1.15% up | 64% down | ||
| 14 | Regeneron PharmaceuticalsREGN · Health Care | AED 7.3B | AED 363.9B | AED 3,518.18 | 0.02% up | 36% up | ||
| 15 | BridgeBio PharmaBBIO · Health Care | AED 7.4B | AED 55.6B | AED 285.32 | 1.16% up | 17% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | AED 9.4B | AED 27.6B | AED 79.29 | 2.23% up | 83% up | ||
| 17 | Elanco Animal HealthELAN · Health Care | AED 14.8B | AED 48.6B | AED 97.25 | 2.44% up | 20% up | ||
| 18 | GenmabGMAB · Health Care | AED 19.4B | AED 116.1B | AED 188.36 | 1.29% down | 70% up | ||
| 19 | Jazz PharmaceuticalsJAZZ · Health Care | AED 19.7B | AED 57.5B | AED 896.49 | 1.41% up | 37% up | ||
| 20 | Royalty PharmaRPRX · Health Care | AED 32.9B | AED 145.4B | AED 252.87 | 0.25% up | 78% up | ||
| 21 | ZoetisZTS · Health Care | AED 33.2B | AED 125.3B | AED 308.34 | 0.57% up | 29% down | ||
| 22 | Abbott LaboratoriesABT · Health Care | AED 47.5B | AED 665B | AED 383.94 | 0.16% down | 17% down | ||
| 23 | ViatrisVTRS · Health Care | AED 52.9B | AED 87B | AED 75.93 | 1.10% up | 96% up | ||
| 24 | GSKGSK · Health Care | AED 70.5B | AED 360B | AED 179.62 | 0.67% down | 6% up | ||
| 25 | Novo NordiskNVO · Health Care | AED 71.4B | AED 641.9B | AED 145.65 | 2.56% down | 17% down | ||
| 26 | SanofiSNY · Health Care | AED 76.2B | AED 418B | AED 174.09 | 0.26% down | 4% down | ||
| 27 | NovartisNVS · Health Care | AED 105.5B | AED 1.08T | AED 573.17 | 1.92% down | 25% up | ||
| 28 | AstraZenecaAZN · Health Care | AED 108.8B | AED 1.02T | AED 658.02 | 1.70% down | 2% up | ||
| 29 | Takeda PharmaceuticalTAK · Health Care | AED 112.3B | AED 250.9B | AED 78.52 | 1.20% down | 54% up | ||
| 30 | Eli LillyLLY · Health Care | AED 156.1B | AED 4.55T | AED 5,107.89 | 1.75% down | 35% up | ||
| 31 | Bristol-Myers SquibbBMY · Health Care | AED 165.7B | AED 450.9B | AED 220.59 | 2.09% down | 34% up | ||
| 32 | Johnson & JohnsonJNJ · Health Care | AED 176.1B | AED 2.44T | AED 1,013.21 | 1.01% down | 38% up | ||
| 33 | Merck & CoMRK · Health Care | AED 181.1B | AED 1.26T | AED 513.08 | 2.55% down | 51% up | ||
| 34 | PfizerPFE · Health Care | AED 238B | AED 590.4B | AED 103.58 | 0.93% down | 14% up | ||
| 35 | AbbVieABBV · Health Care | AED 247.9B | AED 1.88T | AED 1,060.84 | 1.35% down | 26% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6725 AED). 26 companies have no total debt on file and are not ranked here.
Questions and answers
Which pharmaceuticals have the lowest total debt?
Definium Therapeutics (AED 149M), Rhythm Pharmaceuticals (AED 397.3M) and Axsome Therapeutics (AED 689.5M) have the lowest total debt of the 35 pharmaceuticals ranked here as of 18 Nov 2026, 16:31 UTC.
How many pharmaceuticals are in this ranking?
35 are ranked by total debt. 26 more have no total debt on file and are left out rather than ranked at zero.
What are these pharmaceuticals worth together?
The 35 pharmaceuticals ranked by total debt have a combined market value of AED 18.7T as of 18 Nov 2026, 16:31 UTC.
What does ranking by total debt measure?
Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-debt
Underlying data: Yahoo Finance; SEC EDGAR.